lobbying_activities: 2505613

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2505613	64fa282b-83df-45a1-8987-1ff09b7b2a6f	Q3	TAUZIN CONSULTANTS, LLC	400671007	SCILEX HOLDING COMPANY	2020	third_quarter	MMM	Issues related to fair competition, the generic drug market, drug costs, pain management, and non-opioid alternatives. Issues related to COVID-19.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2020-10-09T12:21:33.793000-04:00